We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$505M
AUM Growth
+$40.3M
Cap. Flow
-$3.98M
Cap. Flow %
-0.79%
Top 10 Hldgs %
50.94%
Holding
73
New
4
Increased
2
Reduced
45
Closed
2

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$2.48M
2
CVS icon
CVS Health
CVS
+$836K
3
VLTO icon
Veralto
VLTO
+$792K
4
AVGO icon
Broadcom
AVGO
+$556K
5
INTC icon
Intel
INTC
+$235K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.67M
2
AES icon
AES
AES
+$1.16M
3
DHR icon
Danaher
DHR
+$1.03M
4
VMW
VMware, Inc
VMW
+$791K
5
F icon
Ford
F
+$706K

Sector Composition

Rank Sector Weight
1 Technology 31.63%
2 Healthcare 28.68%
3 Financials 12.57%
4 Communication Services 6.4%
5 Industrials 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.77T
$43.8M 8.67%
883,610
-12,090
-1% -$560K
AAPL icon
2
Apple
AAPL
$4.99T
$40.2M 7.96%
208,790
-1,577
-0.7% -$291K
LLY icon
3
Eli Lilly
LLY
$1.09T
$32.7M 6.47%
56,071
-284
-0.5% -$166K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.08T
$28.6M 5.66%
204,720
-820
-0.4% -$110K
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$20.7M 4.09%
38,928
-267
-0.7% -$129K
AMZN icon
6
Amazon
AMZN
$2.48T
$20.5M 4.06%
134,837
-400
-0.3% -$56.1K
JPM icon
7
JPMorgan Chase
JPM
$950B
$18.8M 3.73%
110,766
-395
-0.4% -$59.9K
MS icon
8
Morgan Stanley
MS
$333B
$18.7M 3.71%
200,683
-3,810
-2% -$305K
MSFT icon
9
Microsoft
MSFT
$2.92T
$16.7M 3.31%
44,472
-245
-0.5% -$87.2K
V icon
10
Visa
V
$697B
$16.5M 3.27%
63,398
-200
-0.3% -$49.3K
ABBV icon
11
AbbVie
ABBV
$465B
$13.2M 2.62%
85,380
-50
-0.1% -$7.29K
LRCX icon
12
Lam Research
LRCX
$337B
$13.2M 2.61%
168,120
DE icon
13
Deere & Co
DE
$173B
$11.1M 2.19%
27,666
-130
-0.5% -$49K
JNJ icon
14
Johnson & Johnson
JNJ
$643B
$10.5M 2.08%
67,119
-340
-0.5% -$52.1K
AKAM icon
15
Akamai
AKAM
$16.3B
$10.4M 2.06%
87,909
-250
-0.3% -$27.8K
CSCO icon
16
Cisco
CSCO
$456B
$9.54M 1.89%
188,853
-745
-0.4% -$38.1K
CRL icon
17
Charles River Laboratories
CRL
$11.6B
$9.17M 1.82%
38,777
-25
-0.1% -$4.92K
BAC icon
18
Bank of America
BAC
$439B
$9.14M 1.81%
271,514
-6,070
-2% -$177K
EOG icon
19
EOG Resources
EOG
$74.4B
$8.66M 1.72%
71,580
-310
-0.4% -$38.6K
BMY icon
20
Bristol-Myers Squibb
BMY
$130B
$8.64M 1.71%
168,396
-6,124
-4% -$321K
SHW icon
21
Sherwin-Williams
SHW
$87.4B
$8.26M 1.64%
26,477
-90
-0.3% -$24.2K
GLW icon
22
Corning
GLW
$108B
$7.74M 1.53%
254,130
-1,460
-0.6% -$41.7K
ABT icon
23
Abbott
ABT
$187B
$7.72M 1.53%
70,148
DHR icon
24
Danaher
DHR
$140B
$7.21M 1.43%
31,177
-4,848
-13% -$1.03M
PG icon
25
Procter & Gamble
PG
$347B
$6.05M 1.2%
41,261

Similar funds

J.P. Marvel Investment Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, J.P. Marvel Investment Advisors held 73 positions worth $505M, up 8.7% from $464M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

J.P. Marvel Investment Advisors's Q4 2023 filing shows 4 new, 2 increased, 45 reduced and 2 closed positions. Its largest new stake was Adobe: 4,299 shares worth $2.56M. The largest sale was Pfizer, an estimated $1.67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • J.P. Marvel Investment Advisors's largest Q4 2023 buy was Adobe: 4,299 shares worth $2.56M.
  • J.P. Marvel Investment Advisors added most to CVS Health in Q4 2023, an estimated $836K increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2023 reduction was Pfizer, cutting an estimated $1.67M.
  • J.P. Marvel Investment Advisors fully exited AES in Q4 2023, selling an estimated $1.16M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 51% of its $505M portfolio in Q4 2023.
  • J.P. Marvel Investment Advisors opened 4 new positions and closed 2 in Q4 2023.
  • J.P. Marvel Investment Advisors's portfolio value rose 8.7% quarter-over-quarter to $505M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.